drugset / Trial / NCT01344148

Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China.

NCT01344148

RandomizedParallel-groupOpen-labelTreatment

Summary

To determine the best time to begin anti-HIV(Acquired Immunodeficiency Syndrome) treatment in individuals who co-infected with HIV and tuberculosis (Tb). This prospective, randomized study is being conducted on HIV/Tb co-infected patients in China to evaluate and compare the efficacy of antiretroviral therapy after 2 weeks TB treatment versus deferred ART initiated 8 weeks after initiation of TB treatment.

Timeline

Start
2009-02
Primary completion
2011-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Efavirenz Other / unclassified
Subject Lamivudine Other / unclassified
Subject Stavudine Other / unclassified
Subject Zidovudine Small molecule
Background Ethambutol Small molecule
Background Isoniazid Small molecule
Background Pyrazinamide Small molecule
Background Rifabutin Small molecule
Background Rifampin Small molecule

Indications